Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date December 31, 2022 · Filed June 05, 2023
Section 16 reporting ended · disclosed 2023-06-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,462 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 13,462 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2023 Filed May 2, 2023 20:19 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-23-014089 · form4.xml · derivative · entry 6 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:19 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 200 | $127.56 | $25,512.00 |
DisclosureSEC source: 0001127602-23-014089 · form4.xml · nonDerivative · entry 5 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,462 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.42 to $127.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:19 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,300 | $126.72 | $544,896.00 |
DisclosureSEC source: 0001127602-23-014089 · form4.xml · nonDerivative · entry 4 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,662 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.36 to $127.26. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder, Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:19 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,500 | $125.57 | $690,635.00 |
DisclosureSEC source: 0001127602-23-014089 · form4.xml · nonDerivative · entry 3 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,962 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.30 to $126.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:19 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 10,000 | $97.69 | $976,900.00 |
DisclosureSEC source: 0001127602-23-014089 · form4.xml · nonDerivative · entry 2 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:19 UTC | CONMED Corp CNMD · Entity 4691 | GiftCommon Stock | 626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014089 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,462 Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:16 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 40 | $98.67 | $3,946.80 |
DisclosureSEC source: 0001127602-23-012185 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,088 Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 10 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 9 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,400 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,000 | $96.08 | $480,381.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 6 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,000 | $78.76 | $393,800.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 5 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,400 | $96.25 | $519,723.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 4 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,400 | $59.96 | $323,784.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 3 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 8 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2033-03-01 F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · derivative · entry 7 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 736 | $96.16 | $70,773.76 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 2 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008749 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2022 Filed Jan 10, 2023 21:47 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 24 | $84.21 | $2,021.04 |
DisclosureSEC source: 0001127602-23-001227 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · Special Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,284 Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:14 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 26 | $76.16 | $1,980.16 |
DisclosureSEC source: 0001127602-22-023446 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,260 Read SEC document |
| June 30, 2022 Filed Jul 6, 2022 20:11 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 22 | $90.97 | $2,001.34 |
DisclosureSEC source: 0001127602-22-018923 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,234 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:39 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 45 | $141.12 | $6,350.40 |
DisclosureSEC source: 0001127602-22-011210 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,212 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 11,157 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · derivative · entry 12 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 11,157 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,600 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · derivative · entry 11 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 5,600 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,610 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · derivative · entry 10 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,610 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,390 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · derivative · entry 9 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,610 Underlying: Common Stock · 1,390 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 11,157 | $142.50 | $1,589,872.50 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 8 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 11,157 | $78.76 | $878,725.32 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 7 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,600 | $142.50 | $798,000.00 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 6 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,600 | $59.96 | $335,776.00 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 5 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,610 | $142.42 | $514,141.25 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 4 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.40 to $142.54. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 3,610 | $41.93 | $151,367.30 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 3 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,390 | $143.30 | $199,181.44 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 2 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.28 to $143.34. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,390 | $41.93 | $58,282.70 |
DisclosureSEC source: 0001127602-22-008585 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:51 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008087 · form4.xml · derivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2032-03-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,755 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 12 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 3,755 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,245 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 11 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,755 Underlying: Common Stock · 1,245 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,343 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 10 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,157 Underlying: Common Stock · 3,343 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 500 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 9 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 500 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,755 | $149.46 | $561,206.15 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 8 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.56. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 3,755 | $97.69 | $366,825.95 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 7 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,245 | $150.00 | $186,750.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 6 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,245 | $97.69 | $121,624.05 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 5 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,343 | $149.41 | $499,481.64 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 4 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 3,343 | $78.76 | $263,294.68 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 3 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 500 | $150.03 | $75,015.35 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 2 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.16. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 500 | $78.76 | $39,380.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:33 UTC | CONMED Corp CNMD · Entity 4691 | OtherCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003389 · form5.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · daughter Disclosed balance after: 450 F1 · ownership.direct: Mr. Jonas' daughters became independent, no longer sharing the same house, during 2021, and, accordingly, Mr. Jonas no longer holds an indirect interest in shares they hold. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 21:13 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 14 | $134.67 | $1,885.38 |
DisclosureSEC source: 0001127602-22-000844 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 15:26 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 16 | $124.29 | $1,988.64 |
DisclosureSEC source: 0001127602-21-026386 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,153 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:39 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 11,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-21-025507 · form4.xml · derivative · entry 5 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.